Used to treat fungus infections, the Ultramicrosize Griseofulvin tablets had sales nearly of $16.7m for the twelve months ended 30 June 2012 in the US market, according to IMS Health data.
Rising Pharmaceuticals is a finished dosage form generics subsidiary of ACETO Corporation, which markets, sells and distributes products for human health, pharmaceutical ingredients and performance chemicals.